As of 2025-05-18, the Intrinsic Value of Jacobson Pharma Corporation Ltd (2633.HK) is 2.14 HKD. This 2633.HK valuation is based on the model Discounted Cash Flows (Growth Exit 5Y). With the current market price of 1.21 HKD, the upside of Jacobson Pharma Corporation Ltd is 76.60%.
The range of the Intrinsic Value is 1.63 - 3.11 HKD
Based on its market price of 1.21 HKD and our intrinsic valuation, Jacobson Pharma Corporation Ltd (2633.HK) is undervalued by 76.60%.
Range | Selected | Upside | |
a | |||
DCF (Growth 5y) | 1.63 - 3.11 | 2.14 | 76.6% |
DCF (Growth 10y) | 1.84 - 3.44 | 2.39 | 97.6% |
DCF (EBITDA 5y) | 1.44 - 1.86 | 1.71 | 41.0% |
DCF (EBITDA 10y) | 1.72 - 2.36 | 2.07 | 71.1% |
Fair Value | 0.63 - 0.63 | 0.63 | -47.69% |
P/E | 1.08 - 1.25 | 1.19 | -1.7% |
EV/EBITDA | 0.84 - 1.26 | 1.07 | -11.6% |
EPV | 2.36 - 3.77 | 3.06 | 153.1% |
DDM - Stable | 0.84 - 2.11 | 1.48 | 21.9% |
DDM - Multi | 0.88 - 1.83 | 1.20 | -0.5% |
Market Cap (mil) | 2,420.27 |
Beta | 0.10 |
Outstanding shares (mil) | 2,000.22 |
Enterprise Value (mil) | 2,614.33 |
Market risk premium | 5.98% |
Cost of Equity | 8.47% |
Cost of Debt | 4.25% |
WACC | 7.29% |